Press Releases

Lumicell Expands Board With Addition of Michael Ruettgers

Industry executive with history of building successful Boston-based businesses will serve as an advisor to the development of Lumicell’s growth and long-term business strategies


Wellesley, Mass., Aug. 15, 2018 — Lumicell, Inc., an innovation leader in molecular imaging within healthcare focused in cancer, perfusion, wound care and infection, today announced the addition of Michael Ruettgers to its Board of Directors.

“We are excited to add Mike’s leadership to our board. He knows how to build winning teams and has experience in bringing quality products and services to life,” said Andrey Zarur, Chairman Board of Directors, Lumicell. “His decades of experience in scaling global businesses – and in healthcare, technology and regulatory issues –  will help us think bigger and drive long-term growth.”


“I’m thrilled to play a role in Lumicell’s growth,” said Ruettgers. “It’s important get the company’s groundbreaking technology into the hands of physicians where it can improve patient outcomes and reduce healthcare costs. It’s exhilarating to work with growing companies like Lumicell, as they have the potential for the largest amount of growth and industry impact. The company’s core technologies will benefit patients and physicians, healthcare practices, support the company, and encourage stakeholders.”


Ruettgers, also known as Mike, is a retired special advisor to EMC Corporation, where he previously held leadership roles including executive chairman of the board, CEO and president. Under Mike’s leadership, EMC became the global leader in the storage network market, became one of the fastest growing companies in the United States and achieved the highest single-decade performance (1990-2000) of any listed stock in the history of the New York Stock Exchange.  Mike left his leadership role formally in the mid 2000s with over $23B in revenue and 24,000 employees. 


Ruettgers currently sits on the Board of Trustees of Lahey Clinic, on the Executive Committee of the Board of Trustees of Holy Cross College, the Board of Virsec Systems and Foreground Systems and is a member of the Massachusetts Business Roundtable, the Massachusetts High Tech Council, and Business for Better Schools.


A frequent author on key policy and technology issues, Ruettgers was named one of the World's Top 25 Executives by BusinessWeek; one of the Best Chief Executive Officers in America by Worth magazine; one of the 25 Most Powerful People in Networking in 2000 by Network World; and Chief Executive Officer of the Year for 2000 by Massachusetts Investor's Digest. He holds a BS from Idaho State University and an MBA from Harvard Business School.


“Throughout his career, Mike has built an exceptional reputation in successfully growing and leading companies. His expertise will raise the team’s sights toward becoming the global leader in precision medical imaging,” said Dave Furneaux, lead investor, CEO of BlueIO and Managing Partner of Kodak Venture Partners. “We are delighted to have Mike’s leadership on Lumicell’s board and look forward to his guidance bringing exceptional value to the development of Lumicell.”


About Lumicell, Inc.
Lumicell is a technology leader in the field of image-guided cancer surgery. The company is developing a novel system that enables real-time detection of tumor tissue in patients so that no cancer cells are left behind during surgery. The company’s LUM System has unprecedented ability to see and remove cancer cells remaining in the surgical cavity – beyond the margin of the specimen – and has the potential to significantly improve surgical outcomes and reduce healthcare costs by eliminating the need for repeat surgeries. Lumicell is investigating the LUM System in patients undergoing surgery for breast cancer, ovarian cancer, prostate cancer, brain cancer, colorectal, esophageal and pancreatic cancers. Additional future indications are planned to include perfusion, wound care and infection and surgeries for lung and liver cancer. For more information, please visit



Media contact: Ali Buckneberg
Phone number: 612-334-5960